Goodman, Michelle S.
Vila-Rodriguez, Fidel
Barwick, Melanie
Burke, Matthew J.
Downar, Jonathan
Hunter, Jonathan
Kaster, Tyler S.
Knyahnytska, Yuliya
Kurdyak, Paul
Maunder, Robert
Thorpe, Kevin
Trevizol, Alisson P.
Voineskos, Daphne
Zhang, Wei
Blumberger, Daniel M.
Funding for this research was provided by:
Fondation Brain Canada
Article History
Received: 30 October 2023
Accepted: 19 December 2023
First Online: 8 January 2024
Declarations
:
: Ethics approval was obtained by the Centre for Addiction and Mental Health Research Ethics Board (reference number 109–2021) and the University of British Columbia and the Vancouver Coastal Health Research Institute Research Ethics Boards, (reference number H22-00151). The informed consent process is initiated before the patient agrees to participate in the study and will be obtained according to REB and GCP guidelines. All patients referred by a general physician or psychiatrist will undergo an extensive consultation with a brain stimulation psychiatrist at each study site, who will determine suitability for referral to this trial. Patients referred to the trial will then be assessed for eligibility by qualified research personnel who will obtain consent. Patients will be informed that they can withdraw participation at any point during the study, and the rights and welfare of the patients will be protected.
: Not applicable.
: FVR receives research support from the Canadian Institutes of Health Research, Brian Canada, Michael Smith Foundation for Health Research, Vancouver Coastal Health Research Institute, and in-kind equipment support for an investigator-initiated trial from MagVenture. He has participated in an advisory board for Janssen. MB receives salary support from the SickKids Research Institute, and unrelated implementation research funding from CIHR, NIH, and the Helmsley Trust. MJB has received research salary support from the Liu Fu Yu Charity Foundation, Sunnybrook Foundation and University of Toronto Department of Psychiatry. MJB reports no conflicts of interest. JD has received research support from NIH, CIHR, Brain Canada, Ontario Brain Institute, the Klarman Family Foundation, the Krembil Foundation, Arrell Family Foundation, and the Buchan Family Foundation, in-kind equipment support for investigator-initiated trials from MagVenture, is an advisor for BrainCheck, Arc Health Partners and Salience Neuro Health, and is a co-founder of Ampa Health. JH has received research support from CIHR, NIH, SUAP, the University Health Network-Mount Sinai Alternative Funding Program, Physicians Services Incorporated Foundation, Canadian Breast Cancer Research Alliance, and Science of Caring, He receives research and salary support from the Pencer Family Chair in Applied General Psychiatry at Sinai Health, funded by Sinai Health and the University of Toronto. TSK has received research support from CIHR and the AFP Innovation Fund. RM has received research support from CIHR, University Health Network-Mount Sinai Alternative Funding Program, and Heart & Stroke Foundation (Canada). He receives research and salary support from the Chair in Health and Behaviour at Sinai Health, funded by Sinai Health and the University of Toronto. DV holds the Labatt Family Professorship in Depression Biology, a University Named Professorship at the University of Toronto. She receives research support from CIHR, NIMH, the Centre for Addiction and Mental Health (CAMH), The Centre for Mental Health at University Health Network and the Department of Psychiatry at the University of Toronto. DV declares no biomedical interests or conflicts. WZ acknowledges the support of the Michael Smith Health Research Scholar Award. Her research has also been funded by CIHR, UBC Health Ministry of Health Research Seed Grant Program, BC Lung Foundation, BC SUPPORT Unit, Canadian Glycomics Network, and Pfizer Canada. Neither of the above research funding is in relation to this submitted work and related subjects. WZ declares that she has no competing interests. DMB receives research support from the Canadian Institutes of Health Research (CIHR), National Institutes of Health – US (NIH), Brain Canada Foundation and the Temerty Family through the CAMH Foundation and the Campbell Family Research Institute. He received research support and in-kind equipment support for an investigator-initiated study from Brainsway Ltd. and he was the site principal investigator for three sponsor-initiated studies for Brainsway Ltd. He received in-kind equipment support from Magventure for investigator-initiated studies. He received medication supplies for an investigator-initiated trial from Indivior. He has participated in an advisory board for Janssen. He has participated in an advisory board for Welcony Inc. MSG, YK, KT, PK, and APT report no completing interests.